MSA with a parkinsonian variant (MSA-P) and PD share many common clinical presentations, such as parkinsonism and autonomic failure to mention just a few. The early differential diagnosis of these two disorders has been established more or less empirically despite a lack of a subjective, satisfactory biomarker. Neuroimaging has revolutionized in-vivo visualization of neuromelanin and iron in the substantial nigra (SN), which has been considered as the primary and predominant pathophysiological change in PD patients. We found significant neuromelanin changes in the SN in patients with MSA-P compared with PD and HC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords